I've already stated the opinion that in the 3+ years I've been invested here, that this is the most critical juncture in my short experience with this company and stock.  

I take note of the fact that in pretty much every investor presentation I've seen with DM, that he loves to tout the company's success in raising money and in the "tight" nature of the stock, how they keep a close eye on costs and dilution. While I cannot envision an investor presentation absent a financial update, I have to acknowledge that it is a possibilty.

However if they do have something that's both material and positive to annouce....I can't think of a much better venue than what's coming up with B&B next week.  Side question....Can someone post the exact time/date of that presentation?

I'm thinking back to early 2015 and Ziopharm....a stock that in October of 2014 was trading for less than $3 per share, and was at $5 when that company announced a partnership with the MD Anderson Cancer Centre on Jan 13th 2015.  They made that splash at a JP Morgan Healthcare Conference and the stock was off to the races almost tripling off that $5 starting point.  

I know many here are expecting much more than $5 or $6 per share, but personally I'd be thrilled to get there...after all, you can't get to $10 or $20 without hitting $5 or $6 on the way.

If there is a big announcement though I hope its better than Ziopharm's partnership deal....they forked over $50 million in shares to Anderson, and then another $7.5 million (also in stock) to fast track the deal so they could announce it at the Conference....it worked, but after that their PPS was cut in half and more.  

The devil is always in the details.